Zafrens is developing a high-throughput single-cell functional screening platform, Z-Screen, that enables cross-modality drug discovery.  Z-Screen expands the conventional 96-well experimental format to 50,000 - 200,000 wells with imaging and single-cell multiomic capabilities integrated into every well. Complex cellular co-culture interactions can now be resolved at the molecular and functional levels simultaneously.